ストックスクリーナーアプリを入手
3.58
9.82%
-0.39
アフターアワーズ：
3.60
0.02
+0.56%
前日終値:
$3.97
開ける：
$3.93
24時間の取引高:
3.99M
Relative Volume:
1.07
時価総額：
$1.30B
収益：
$2.59M
当期純損益:
$-137.89M
株価収益率:
-4.4198
EPS:
-0.81
ネットキャッシュフロー:
$-69.76M
1週間 パフォーマンス:
+4.99%
1か月 パフォーマンス:
-4.79%
6か月 パフォーマンス:
-13.32%
1年 パフォーマンス:
+40.39%
1日の値動き範囲:
$3.58
$3.935
1週間の範囲:
$3.44
$4.01
52週間の値動き範囲:
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
名前
Ataibeckley Inc
セクター
電話
49 89 2153 9035
住所
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.58 | 1.44B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | 開始されました | Guggenheim | Buy |
| 2025-10-13 | 開始されました | Needham | Buy |
| 2025-07-29 | 開始されました | Oppenheimer | Outperform |
| 2024-11-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-04-03 | アップグレード | Maxim Group | Hold → Buy |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2021-11-30 | 開始されました | Maxim Group | Buy |
| 2021-11-11 | 開始されました | ROTH Capital | Buy |
| 2021-10-18 | 開始されました | H.C. Wainwright | Buy |
| 2021-09-01 | 開始されました | Jefferies | Buy |
| 2021-07-13 | 開始されました | Berenberg | Buy |
| 2021-07-13 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-13 | 開始されました | Cantor Fitzgerald | Buy |
| 2021-07-13 | 開始されました | Citigroup | Buy |
| 2021-07-13 | 開始されました | Cowen | Outperform |
| 2021-07-13 | 開始されました | Credit Suisse | Outperform |
| 2021-07-13 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 開始されました | Aegis Capital | Buy |
すべてを表示
Ataibeckley Inc (ATAI) 最新ニュース
5 Psychedelic Stocks to Buy Now - The Motley Fool
Guggenheim, JonesResearch Coverage and BPL-003 Control Might Change The Case For Investing In AtaiBeckley (ATAI) - simplywall.st
HC Wainwright remains bullish on AtaiBeckley Inc. (ATAI) - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential In Innovative Mental Health Treatments - DirectorsTalk Interviews
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Guggenheim Initiates Buy Rating for AtaiBeckley (ATAI) With $11 PT, Cites Leadership in Psychiatry - Insider Monkey
H.C. Wainwright Remains Bullish on AtaiBeckley Inc. (ATAI) - Insider Monkey
Ataibeckley completes redomiciliation to the US - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem With Over 200% Upside Potential - DirectorsTalk Interviews
Psychedelic: Analyst initiates Atai Beckley with Buy rating - TipRanks
Assessing AtaiBeckley (ATAI) Valuation After Recent Share Price Pullback - simplywall.st
Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... - Proactive Investors
Assessing AtaiBeckley (ATAI) Valuation After Trial Success Index Addition Capital Raise And US Move - Yahoo Finance
AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies - Proactive financial news
AtaiBeckley Weighs Late Stage Options After Milestones And US$300m Raise - simplywall.st
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data - Yahoo Finance
Guggenheim Initiates AtaiBeckley at Buy With $11 Price Target - marketscreener.com
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 - Finviz
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation - Finviz
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive financial news
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
Ataibeckley Inc (ATAI) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):